•Drug-Drug Interaction Risk Assessment Strategies for Biologics in Inflammatory Bowel Disease: A Literature-Based Evidence Mini-Review
•Montmorillonite@Metal oxide nanocomposites enables multitarget therapy for inflammatory bowel disease treatment
•Therapeutic application of probiotic extracellular vesicles in inflammatory bowel disease
•Two birds with one stone: Charge flip assisted colon-targeting hybrid nanoplatform for both drug delivery and proinflammatory factor scavenging
•Metabolomics predict treatment response to vedolizumab in pediatric IBD: results from the prospective VedoKids cohort study